|
Chief Medical Operating Officer Dr. Stephane Lubicz consultant with Mediscience on the clinical aspects of the CD Ratiometer project. -- has over 20 years of business and private practice experience in gynecology oncology. Responsible for coordinating the management of the clinical development of the Company's platform projects with focus on implementing clinical study protocols, including those for projects in the U.S as well as Mexico and South/Central America. He received his Bachelor of Science Degree, Cum Laude from Free University, Brussels, Belgium and his M.D. degree fromt Free University as well. In addition to his active role as a practicing New York City physician, specializing in Gynecologic Oncology, his professional experience covers a broad range of activities in the Research and Development of pharmaceutical products. Specifically, this includes United States consultant to B & A Inc., a company that operates as a service group for coordinating and organizing clinical trials (Phase I, II, III) in Mexico and throughout Latin America . As Medical Director, Clinical Development Oncology for Daiichi Pharmaceutical Corp. he was responsible for coordinating and the management of the clinical development of the Company's drug projects with focus on implementing clinical study protocols, including those for projects in the U.S as well as Mexico and South/Central America. He has been an active participant in the working as a consultant with Mediscience on the clinical aspects of the CD Ratiometer project. | 